Skip to main content

Chemomab Therapeutics Ltd. American Depositary Share (CMMB)

About The Company

CMMB Stock Market Logo

Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet need. The company’s lead candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. It is advancing three Phase 2 clinical trials in parallel forCM-101 treating rare fibrotic conditions.

IPO Year Sector Industry
2019 Health Care Biotechnology: Pharmaceutical Preparations

Chemomab Therapeutics Ltd. American Depositary Share (CMMB) Latest News

Company Contact & Address (CMMB)

Corporate Headquarters Phone Website
+972 773310156 Official CMMB Website

CMMB Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ CMMB

Jobs & Employment at Chemomab Therapeutics Ltd. American Depositary …

LinkedIn Company Page
Official Career & Employment Page View LinkedIn page for the jobs & careers details.

Related & Similar Stock Symbols

OXM Stock Market Price & News


Oxford Industries Inc. Common Stock

NEP Stock Market Price & News


NextEra Energy Partners LP Common Units representing …

AGILW Stock Market Price & News


AgileThought Inc. Warrant